Focal segmental glomerulosclerosis screening: Difference between revisions
No edit summary |
|||
Line 2: | Line 2: | ||
{{Focal segmental glomerulosclerosis}} | {{Focal segmental glomerulosclerosis}} | ||
{{CMG}}; {{AE}} | {{CMG}}; {{AE}} {{MKK}} | ||
==Overview== | ==Overview== | ||
There is insufficient evidence to recommend routine screening for focal segmental glomerulosclerosis. | There is insufficient evidence to recommend routine screening for focal segmental glomerulosclerosis. |
Latest revision as of 20:12, 4 June 2018
Focal segmental glomerulosclerosis Microchapters |
Differentiating Focal segmental glomerulosclerosis from other Diseases |
---|
Diagnosis |
Treatment |
Case Studies |
Focal segmental glomerulosclerosis screening On the Web |
American Roentgen Ray Society Images of Focal segmental glomerulosclerosis screening |
Directions to Hospitals Treating Focal segmental glomerulosclerosis |
Risk calculators and risk factors for Focal segmental glomerulosclerosis screening |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Manpreet Kaur, MD [2]
Overview
There is insufficient evidence to recommend routine screening for focal segmental glomerulosclerosis.
Screening
There is insufficient evidence to recommend routine screening for focal segmental glomerulosclerosis screening.